Simos Simeonidis

Simos Simeonidis

Plus aucun poste en cours

54 ans
Finance
Consumer Services
Health Technology

Profil

Simos Simeonidis worked as a Senior Biotech Analyst and Managing Director at various firms including Cowen & Co. LLC, Rodman & Renshaw LLC, and Royal Bank of Canada.
He also served as an Independent Director at Regulus Therapeutics, Inc. and as a Senior Managing Director & Partner at Sarissa Capital Acquisition Corp.
Dr. Simeonidis holds an undergraduate degree from Loyola University of Chicago, an MBA from The Wharton School of the University of Pennsylvania, and graduate and doctorate degrees from Columbia University College of Physicians & Surgeons.

Anciens postes connus de Simos Simeonidis

SociétésPosteFin
Chief Executive Officer 01/01/2023
Chief Executive Officer 01/01/2023
REGULUS THERAPEUTICS INC. Director/Board Member 06/12/2022
SARISSA CAPITAL ACQUISITION CORP. Corporate Officer/Principal 01/11/2021
Analyst-Equity 01/06/2017
Voir l'expérience en détail de Simos Simeonidis

Formation de Simos Simeonidis

Loyola University of Chicago Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin
Columbia University College of Physicians & Surgeons Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Simos Simeonidis

Relations

100 +

Relations au 1er degré

15

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées1
REGULUS THERAPEUTICS INC.

Health Technology

Entreprise privées10

Finance

Health Technology

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Finance

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Simos Simeonidis